Evecxia Therapeutics
Manufacturing · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
2 Davis Dr, Durham, North Carolina, 2770...Phone Number
(919) 597-8762Website
www.evecxia.comRevenue
<$5 MillionIndustry
About Evecxia Therapeutics
Evecxia Therapeutics is focused on harnessing the therapeutic potential of 5-hydroxytryptophan (5-HTP) to treat mental illness, aiming to improve the lives of those affected by disabling conditions inadequately addressed by current therapies. The company is pioneering serotonin synthesis amplification as a novel approach to enhance mood and reduce negative behaviors associated with mental disorders. Evecxia is developing proprietary drug delivery technologies to optimize the therapeutic effects of 5-HTP, making it a viable treatment option. Their mission is to help individuals lead fuller, more meaningful lives by addressing the limitations of existing antidepressant medications.Explore more
Evecxia Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Evecxia Therapeutics
Compare insights from companies similar to Evecxia Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Evecxia Therapeutics Tech Stack
A closer look at the technologies used by Evecxia Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Evecxia Therapeutics
Sign Up For FreeTo access detailed company insights
Evecxia Therapeutics is focused on harnessing the therapeutic potential of 5-hydroxytryptophan (5-HTP) to treat mental illness, aiming to improve the lives of those affected by disabling conditions inadequately addressed by current therapies. The company is pioneering serotonin synthesis amplification as a novel approach to enhance mood and reduce... Read More
